Table 3.
n | Total | TAU | GENE | p-value | ||
---|---|---|---|---|---|---|
| ||||||
QIDS response | 8 week | 155 | 56 (36.1%) | 27 (34.6%) | 29 (37.7%) | 0.693 |
6 month | 125 | 66 (52.8%) | 36 (56.3%) | 30 (49.2%) | 0.429 | |
| ||||||
QIDS remission | 8 week | 155 | 20 (12.9%) | 8 (10.3%) | 12 (15.6%) | 0.323 |
6 month | 125 | 30 (24.0%) | 15 (23.4%) | 15 (24.6%) | 0.880 | |
| ||||||
CDRS-R response | 8 week | 155 | 110 (71.0%) | 56 (71.8%) | 54 (70.1%) | 0.819 |
6 month | 125 | 100 (80.0%) | 55 (86.9%) | 45 (73.8%) | 0.089 | |
| ||||||
CDRS-R remission | 8 week | 155 | 50 (32.3%) | 22 (28.2%) | 28 (36.4%) | 0.277 |
6 month | 125 | 69 (47.2%) | 29 (46.9%) | 29 (47.5%) | 0.941 |
Note: CDRS-R = Children’s Depression Rating Scale, Revised; GENE = Pharmacogenetics Guided Treatment; QIDS = Quick Inventory of Depressive Symptomatology; TAU = Treatment As Usual